FDA Decision Has Plan B Headed For Behind-The-Counter Sale
This article was originally published in The Tan Sheet
FDA appears to be ready to create a third class of drugs
You may also be interested in...
It was only after prolonged litigation led a federal judge in 2013 to order FDA not to allow political interference with its science-based decisions that Plan B and generic equivalents became available OTC without age restrictions. “Hopefully, all I can say, it won't happen again,” says reproductive rights advocate Kirsten Moore.
Barr is running an advertising campaign in college newspapers for its Plan B emergency contraceptive while the company awaits FDA's decision on an OTC switch of the drug
FDA Acting Commissioner Lester Crawford's bid for the permanent post has been cast further into doubt by a Republican joining the list of Senators threatening holds on his nomination